# Silodosin Versus Tamsulosin for Treatment of Ureteral Stones

> **NCT02369744** · PHASE4 · TERMINATED · sponsor: **Albert Einstein Healthcare Network** · enrollment: 1 (actual)

## Conditions studied

- Ureteral Calculus
- Ureterolithiasis
- Ureteral Stone

## Interventions

- **DRUG:** Silodosin
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT02369744
- **Lead sponsor:** Albert Einstein Healthcare Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** due to lack of suitable patient population
- **Last updated:** 2020-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02369744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02369744, "Silodosin Versus Tamsulosin for Treatment of Ureteral Stones". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02369744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*